COMMUNIQUÉS West-GlobeNewswire

Lantos Technologies Launches the Only FDA-Cleared 3D Ear Scanning System
20/03/2019
Innovative Technology Breaks the Mold and Enables Audiologists to Modernize Their Practice, Unlocks Personalized Hearing Solutions for Patients WILMINGTON, Mass., March 20, 2019 (GLOBE NEWSWIRE) -- Lantos Technologies [...]
March of Dimes and AMAG Pharmaceuticals, Inc., Announce First Joint Supportive Pregnancy Care Program
20/03/2019
First Site Launches in Springfield, Mass. Offering an Innovative Model of Group Prenatal Care ARLINGTON, Va. and WALTHAM, Mass., March 20, 2019 (GLOBE NEWSWIRE) -- March of Dimes and AMAG Pharmaceuticals, Inc. (NASDAQ: [...]
The Joint Corp. to Present at the Cowen and Company 5th Annual Future of the Consumer Conference
20/03/2019
SCOTTSDALE, Ariz., March 20, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management is scheduled to attend the Cowen and [...]
BioSyent Releases Results for Fourth Quarter and Full Year 2018
20/03/2019
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December 31, 2018. Key highlights include: [...]
Spectral Expands its Renal Replacement Therapy Development Program to Include the Home Dialysis Market
20/03/2019
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
Solo Growth Announces Licensing Agreement and Acquisition of Call Right on Operating Retail Cannabis Store in Red Deer, Alberta
20/03/2019
CALGARY, Alberta, March 20, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) is pleased to announce that it has entered into and closed a definitive agreement, effective [...]
Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019
20/03/2019
- Company to provide update on Type B meeting with FDA on Phase 3 clinical trial design for FCX-007 gene therapy candidate for recessive dystrophic epidermolysis bullosa (RDEB) - - Company to highlight updated data from [...]
Canada’s Stem Cell Network Welcomes Renewed Federal Commitment for Stem Cell & Regenerative Medicine Research
20/03/2019
OTTAWA, March 20, 2019 (GLOBE NEWSWIRE) -- Through Budget 2019, the Government of Canada has signalled its continued confidence in Canadian stem cell and regenerative medicine research with a multi-year investment of $ [...]
Le Réseau de cellules souches du Canada se réjouit de l’engagement renouvelé du gouvernement fédéral envers la recherche sur les cellules souches et en médecine régénérative
20/03/2019
OTTAWA, 20 mars 2019 (GLOBE NEWSWIRE) -- Dans son budget de 2019, le gouvernement du Canada a confirmé sa confiance continue dans la recherche canadienne sur les cellules souches et en médecine régénérative avec un [...]
Humana Selects The Inovalon ONE® Platform
20/03/2019
Leading National Health Plan to Implement Inovalon’s Data-Driven Solution Across 17 States to Empower Enhanced Outcomes And Economics BOWIE, Md., March 20, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading [...]
Blueberries Medical Appoints Former PharmaCielo CEO Dr. Patricio Stocker as Chief Executive Officer
20/03/2019
Appointment Adds Extensive Strategic Expertise in the Latin American and International Cannabis Industries and Related Capital Markets TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) ( [...]
BeyondSpring to Present Clinical Trial Data on Lead Asset, Plinabulin, at 2019 St. Gallen International Breast Cancer Conference
20/03/2019
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Company will present [...]
Zealand Pharma increases its share capital as a consequence of a new issue of shares
20/03/2019
Company announcement – No. 7/2019 Zealand Pharma increases its share capital as a consequence of a new issue of shares Zealand Pharma A/S' board of directors has exercised an authorization granted by its extraordinary [...]
European Medicines Agengy Issues Certificates for Trogarzo® Manufacturing Sites
20/03/2019
MONTREAL, March 20, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the Wuxi Biologics facilities set to manufacture Trogarzo ® for the European market have [...]
L’agence européenne des médicaments émet les certificats pour les sites de fabrication de Trogarzo(MD)
20/03/2019
MONTRÉAL, 20 mars 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que les installations de Wuxi Biologics, prévues pour la fabrication du Trogarzo MD destiné au [...]
Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
20/03/2019
Company announcement – No. 06 / 2019 Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases Collaboration furthers Alexion’s complement leadership [...]
Interview with Gabriella's Kitchen CEO Margot Micallef -- CFN Media
20/03/2019
SEATTLE, March 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
CB2 Insights Signs Agreement to Acquire Medical Cannabis Clinic Group in Colorado and Arizona
20/03/2019
First acquisition post-RTO to consolidate the US medical cannabis clinical market; increases revenues, patient count and jurisdictions served TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “ [...]
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2018 Financial Results
20/03/2019
BERKELEY HEIGHTS, N.J., March 20, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]

Pages